Adaptimmune Therapeutics PLC (ADAPY) stock
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Adaptimmune Therapeutics's price to book ratio was 35.9× on Apr 30, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 5.8× to 83.6×, with a median of 14.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 35.9× | +25.6 |
| 2024 | Dec 31, 2024 | 10.3× | −1.9 |
| 2023 | Dec 29, 2023 | 12.3× | −0.4 |
| 2022 | Dec 30, 2022 | 12.7× | −1.9 |
| 2021 | Dec 31, 2021 | 14.6× | +1.3 |
| 2020 | Dec 31, 2020 | 13.3× | +8.2 |
| 2019 | Dec 31, 2019 | 5.1× | −30.1 |
| 2018 | Apr 30, 2018 | 35.2× | +18.8 |
| 2017 | Dec 29, 2017 | 16.4× | +9.8 |
| 2016 | Dec 30, 2016 | 6.6× | −13.1 |
| 2015 | Dec 31, 2015 | 19.8× | – |
See a number that looks wrong?